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1. Introduction 
The peptide bond-forming reaction of protein 
synthesis in bacteria [l-3] , yeast [4] , protozoa [S] , 
rat liver [6] , and human tonsils [4] is catalyzed by a 
peptidyl transferase catalytic centre on the larger ib- 
somal subunit. The functioning of this centre can be 
specifically studied, uncoupled from other reactions 
of protein synthesis, by means of the “fragment reac- 
tion” (fig. 1). This reaction system.has been fairly ex- 
tensively characterized with E. coli ribosomes [ 1,3,8- 
lo] , but corresponding studies with eukaryote ribo- 
somes have only just begun [4-61. In the present paper 
we report some general characteristics of the fragment 
reaction using human tonsil ribosomes. Responses to 
monovalent and divalent cations and to alcohol are 
very similar to those with E. coli and yeast ribosomes, 
but there are some striking differences in sensivity to 
antibiotic inhibitors. 
2. Methods 
Ribosomes from human tonsils and rat liver were 
prepared as described elsewhere [ 1 l] . Subunits from 
the tonsil ribosomes were prepared by the method of 
Martin and Wool [ 121. The standard incubation mix- 
ture for assay of the fragment reaction contained (be- 
fore addition of alcohol) the following components: 
0.05 M-Tris/HCl buffer (pH 7.4), 0.4 M KCl, 0.02 
M-Mg acetate, 1 mM-puromycin, 1mg/ml tonsil ribo- 
somes, and CACCA@I) leu-Ac (about 8 nM; specific 
Fig. 1. Diagrammatic representation of the “fragment reaction” [4,7]. Acetyl-leucine is transferred from CCA to puromycin giving 
Ac-leu-puromycin and CCA. Other substrates can also be used [8]. The reaction is catalysed by preparations of the larger riboso- 
ma1 subunit (as shown) or of complete ribosomes. The fragment reaction has the advantage that interactions between substrates 
and ribosome are confmed to the immediate vicinity of the peptidyl transferase centre. Properties of the catalytic centre can thus 
be specifically examined. 
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Fig. 2. Time course of reaction between CACCA-leu-Ac and puromycin. Conditions as in text. 
activity about 22 curie/mmole; prepared as in [a]). 
100 1.t1 portions were equilibriated at 0”, and the 
reaction initiated by addition of 50 /.d precooled 
ethanol. Formation of Ac-leu-puromycin was esti- 
mated by extraction with ethyl acetate ([9] modified 
from [ 131). The extent of reaction is expressed as the 
percentage of CACCA-leu-Ac converted to Ac-leu-pu- 
romycin. Zero time blanks (less than 3% of added 
radioactivity) were substracted from all estimates. 
3. Results 
3.1. Time course 
Fig. 2 shows that the reaction of CACCA-leu-Ac 
with puromycin was about 50% completed after 40 
min incubation at 0”, and about 90% completed af- 
ter 120 min. The initial rate of reaction was about 
twice that with rat liver ribosomes (table l), about 
the same as with yeast ribosomes [4] , and about 20% 
that obtained with the best preparations ofE. coli 
ribosomes [ 141 at comparable molar concentration. 
In the absence of puromycin there was very little for- 
mation of ethyl acetate-soluble material. 
3.2. Requirements 
Table 1 shows that tonsil ribosomes can be replaced 
by their 60s but not their 40s subunits, and table 2 
shows that the reaction is unaffected by fusidic acid, 
an inhibitor of transfer factor factor-2 [ 15-161, or by 
GMP-PCP (guanylyl methylenediphosphonate), a GTP 
antagonist [ 171. These observations are in accord with 
the proposition [4] that peptide bond formation in 
mammals, as in lower species, takes place by a simple 
peptidyl transfer eaction, catalysed by an active cent- 
re on the larger ibosomal subunit. 
The fragment reaction with tonsil ribosomes (table l), 
as with ribosomes from E. coli [3,8,18] and yeast [4] , 
is dependent upon K+, Mg2’ and ethanol and takes 
place much less rapidly when CACCA-leu-Ac is replaced 
Table 1 
Factors affecting reaction of CACCA-leu-Ac with puromycin. 
Experimental conditions 
Expt. 1 
% fragment reacted 
Standard system 
minus rbosomes 
tonsil ribosomes replaced by 
rat liver ribosomes 
ribosomes replaced by 
60s subunits 
ribosomes replaced by 
40s subunits 
minus K+ 
minus Mg2+ 
minus ethanol 
Expt. 2 
40 
0 
20 
38 
0 
0 
0 
0 
Standard system 44 
CACCA-leu-Ac replaced by CACCA- 
leu 0 
Conditions as in text unless otherwise indicated. Incubation 
was for 30 min at 0’ C. 
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by CACCA-leu as peptidyl donor. The responses of the 
reaction with tonsil ribosomes to concentrations of K+ 
(fig. 3) and M$ (fig. 4) are similar to the responses 
with ribosomes from E. coli [9] and yeast (unpub- 
lished results). 
3.3. Effects of antibiotics 
Table 2 compares the effects of various antibiotic 
inhibitors of protein synthesis on the fragment reac- 
tion with ribosomes from human tonsils, yeast and E. 
coli. Chloramphenicol, lincomycin and spiramycin III 
inhibit the reaction with E. coli ribosomes but are in- 
active with yeast or tonsil ribosomes. In contrast, ani- 
somycin (and tenuazonic acid to a lesser extent) inhi- 
bits the reaction with yeast and tonsil ribosomes but 
not with E. coli ribosomes. Sparsomycin, am&tin 
and gougerotin inhibit the reaction with all three 
types of ribosome. Anisomycin and gougerotin are 
more active against ribosomes from yeast han from 
human tonsils. These responses correspond with the 
known specificities of these antibiotics towards pro- 
tein synthesis in different species [ 19,20: review] . 
The antibiotic cycloheximide, a protein synthesis 
inhibitor specific to eukaryote systems, has no effect 
on the fragment reaction with tonsil ribosomes (ta- 
ble 2) and little or no effect with yeast ribosomes. 
We conclude that this antibiotic acts on some com- 
ponent of the protein synthetic machinery other 
than the peptidyl transferase centre. The weak acti- 
vity of tenuazonic acid against the fragment reaction 
with tonsil and yeast ribosomes leaves doubt as to 
its site of action. 
4. Discussion 
The peptidyl transfer eaction of protein synthe- 
sis has the following common characteristics in E. 
coli, yeast and man: 
(a) the reaction is catalyzed by a centre on the 
larger ibosomal subunit; 
(b) the peptidyl transferase centre is normally 
dormant in absence of mRNA and the smaller i- 
bosomal subunit, but the activity can be expressed 
with isolated preparations of the larger subunit if 
alcohol is present; 
Table 2 
Effects of antibiotics on the fragment reaction with E. colt, yeast and tonsil rIIosomes 
Reaction with tonsil Concentration (NM) of antibiotic giving 
Antibiotic 
ribosomes (as % of 50% Inhibition with ribosomes from: 
control) in presence 
of 1mM antibiotic E. coli yeast tonsib 
Chloramphenicol c. 100 20 Inactive inactive 
Lincomycin c. 100 3 inactive Inactive 
spiramycin III c. 100 15 inactive inactive 
Anisomycin 15 inactive 1 10 
Tenuazonic acid 54 inactive >lOOO 1000 
Sparsomycm 0 50 5 10 
Amicetin 30 40 1000 100-1000 
Gougerotin 15 30 10 100 
Cycloheximide c. 100 inactive >lOOO inactive 
GMP-PCP and fusidic acid were without effect in all three systems. Data have been compiled from several different assays. Except 
for assays with E. coli ribosomes, conditions were as in text, and incubations were for 30 min at 0’ C. Concentration of inhibitor 
giving 50% inhibition is the mean value of two assays. The lack of effect of GMP-PCP, fusidic acid, anisomycin, cycloheximide and 
tenuazonic acid on the fragment reaction with E. coli ribosomes was observed using similar conditions, but other data for E. coli 
are from another publication [lo], in which CAACCA-met-f was employed as substrate. Data for yeast (Sacchmomyces cerevisiae) 
are from [ 41. Further references to the antibiotics and their sources are noted in a recent review [ 201. 
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Fig. 3. Effect of K+ concentration on reaction of CACCA- 
1euAc with puromycin. Conditions as in text, except that 
K+ concentration was varied as indicated. Incubation was 
for 30 min at 0’ C. 
(c) the reaction requires monovalent and diva- 
lent cations, and has characteristic responses to 
their concentrations; 
(d) the reaction is inhibited by sparsomycin, 
am&tin and gougerotin. 
In spite of these similarities in the peptidyl 
transfer eaction with different species, there must 
be certain differences in the fine structures of the 
peptidyl transferase centres of prokaryote and 
eukaryote ribosomes in view of the specitlcites of 
chloramphenicol, lincomycin and spiramycin III 
to ribosomes from bacteria [20] , and of anisomycin 
to ribosomes from yeast, protozoa (G.A.M.Cross, per- 
sonal communication), rat liver [6] and human tonsils. 
The potent activity of amisomycin is of particular in- 
terest, since it is the only eukaryote-specific inhibitor 
of protein synthesis at present known to act on the 
peptidyl transferase centre. The fragment reaction 
might provide a useful assay for further screening and 
development of peptidyl transferase-specific agents 
which discriminate between different species or, per- 
haps, between different cell types (including tumour) 
of the same species. 
Fig. 4. Effect of Mg2+ concentration on reaction of CACCA-leu-Ac with puromycin. Conditions as in text except that Mg2+ con- 
centration was varied as indicated. Rlbosomes were predialysed for 2 hr against 0.1 mM Mg acetate, 50 mM trisacetate buffer 
(pH 7.4), 10 mM NH4 acetate. Incubation was for 30 min at 0°C. 
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